<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="P04_28_2026To04_28_2026">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001789972</identifier>
        </entity>
        <period>
            <startDate>2026-04-28</startDate>
            <endDate>2026-04-28</endDate>
        </period>
    </context>
    <context id="P04_28_2026To04_28_2026_1TypedMemberffdOfferingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001789972</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-28</startDate>
            <endDate>2026-04-28</endDate>
        </period>
    </context>
    <context id="P04_28_2026To04_28_2026_2TypedMemberffdOfferingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001789972</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-28</startDate>
            <endDate>2026-04-28</endDate>
        </period>
    </context>
    <context id="P04_28_2026To04_28_2026_3TypedMemberffdOfferingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001789972</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>3</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-28</startDate>
            <endDate>2026-04-28</endDate>
        </period>
    </context>
    <context id="P04_28_2026To04_28_2026_4TypedMemberffdOfferingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001789972</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>4</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-28</startDate>
            <endDate>2026-04-28</endDate>
        </period>
    </context>
    <context id="P04_28_2026To04_28_2026_5TypedMemberffdOfferingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001789972</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>5</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-28</startDate>
            <endDate>2026-04-28</endDate>
        </period>
    </context>
    <context id="P04_28_2026To04_28_2026_6TypedMemberffdOfferingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001789972</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>6</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-28</startDate>
            <endDate>2026-04-28</endDate>
        </period>
    </context>
    <context id="P04_28_2026To04_28_2026_7TypedMemberffdOfferingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001789972</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>7</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-28</startDate>
            <endDate>2026-04-28</endDate>
        </period>
    </context>
    <context id="P04_28_2026To04_28_2026_8TypedMemberffdOfferingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001789972</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>8</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-28</startDate>
            <endDate>2026-04-28</endDate>
        </period>
    </context>
    <context id="P04_28_2026To04_28_2026_9TypedMemberffdOfferingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001789972</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>9</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-28</startDate>
            <endDate>2026-04-28</endDate>
        </period>
    </context>
    <context id="P04_28_2026To04_28_2026_1TypedMemberffdOffsetAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001789972</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OffsetAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-28</startDate>
            <endDate>2026-04-28</endDate>
        </period>
    </context>
    <context id="P04_28_2026To04_28_2026_2TypedMemberffdOffsetAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001789972</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OffsetAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-28</startDate>
            <endDate>2026-04-28</endDate>
        </period>
    </context>
    <unit id="Unit_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit_pure">
        <measure>pure</measure>
    </unit>
    <unit id="Unit_shares">
        <measure>shares</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="P04_28_2026To04_28_2026" id="ixv-1239">0001789972</dei:EntityCentralIndexKey>
    <ffd:FormTp contextRef="P04_28_2026To04_28_2026" id="ixv-1240">S-3</ffd:FormTp>
    <ffd:FeeExhibitTp contextRef="P04_28_2026To04_28_2026" id="ixv-1241">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:OffsetClmdInd
      contextRef="P04_28_2026To04_28_2026_1TypedMemberffdOffsetAxis"
      id="hidden164402024">true</ffd:OffsetClmdInd>
    <ffd:OffsetPrrSctyTp
      contextRef="P04_28_2026To04_28_2026_1TypedMemberffdOffsetAxis"
      id="ixv-1243">Equity</ffd:OffsetPrrSctyTp>
    <ffd:TtlPrevslyPdAmt
      contextRef="P04_28_2026To04_28_2026"
      decimals="0"
      id="hidden164402023"
      unitRef="Unit_USD">0</ffd:TtlPrevslyPdAmt>
    <ffd:CombinedProspectusTableNa contextRef="P04_28_2026To04_28_2026" id="ixv-1245">N/A</ffd:CombinedProspectusTableNa>
    <ffd:SubmissnTp contextRef="P04_28_2026To04_28_2026" id="ixv-1360">S-3ASR</ffd:SubmissnTp>
    <dei:EntityRegistrantName contextRef="P04_28_2026To04_28_2026" id="ixv-1361">Cullinan Therapeutics, Inc.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg
      contextRef="P04_28_2026To04_28_2026_1TypedMemberffdOfferingAxis"
      id="ixv-1362">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp
      contextRef="P04_28_2026To04_28_2026_1TypedMemberffdOfferingAxis"
      id="ixv-1363">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl
      contextRef="P04_28_2026To04_28_2026_1TypedMemberffdOfferingAxis"
      id="ixv-1364">Common Stock, par value $0.0001 per share</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg
      contextRef="P04_28_2026To04_28_2026_1TypedMemberffdOfferingAxis"
      id="ixv-1365">true</ffd:Rule457rFlg>
    <ffd:PrevslyPdFlg
      contextRef="P04_28_2026To04_28_2026_2TypedMemberffdOfferingAxis"
      id="ixv-1366">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp
      contextRef="P04_28_2026To04_28_2026_2TypedMemberffdOfferingAxis"
      id="ixv-1367">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl
      contextRef="P04_28_2026To04_28_2026_2TypedMemberffdOfferingAxis"
      id="ixv-1368">Preferred Stock</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg
      contextRef="P04_28_2026To04_28_2026_2TypedMemberffdOfferingAxis"
      id="ixv-1369">true</ffd:Rule457rFlg>
    <ffd:PrevslyPdFlg
      contextRef="P04_28_2026To04_28_2026_3TypedMemberffdOfferingAxis"
      id="ixv-1370">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp
      contextRef="P04_28_2026To04_28_2026_3TypedMemberffdOfferingAxis"
      id="ixv-1371">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl
      contextRef="P04_28_2026To04_28_2026_3TypedMemberffdOfferingAxis"
      id="ixv-1372">Debt Securities</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg
      contextRef="P04_28_2026To04_28_2026_3TypedMemberffdOfferingAxis"
      id="ixv-1373">true</ffd:Rule457rFlg>
    <ffd:PrevslyPdFlg
      contextRef="P04_28_2026To04_28_2026_4TypedMemberffdOfferingAxis"
      id="ixv-1374">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp
      contextRef="P04_28_2026To04_28_2026_4TypedMemberffdOfferingAxis"
      id="ixv-1375">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl
      contextRef="P04_28_2026To04_28_2026_4TypedMemberffdOfferingAxis"
      id="ixv-1376">Depositary Shares</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg
      contextRef="P04_28_2026To04_28_2026_4TypedMemberffdOfferingAxis"
      id="ixv-1377">true</ffd:Rule457rFlg>
    <ffd:PrevslyPdFlg
      contextRef="P04_28_2026To04_28_2026_5TypedMemberffdOfferingAxis"
      id="ixv-1378">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp
      contextRef="P04_28_2026To04_28_2026_5TypedMemberffdOfferingAxis"
      id="ixv-1379">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl
      contextRef="P04_28_2026To04_28_2026_5TypedMemberffdOfferingAxis"
      id="ixv-1380">Subscription Rights</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg
      contextRef="P04_28_2026To04_28_2026_5TypedMemberffdOfferingAxis"
      id="ixv-1381">true</ffd:Rule457rFlg>
    <ffd:PrevslyPdFlg
      contextRef="P04_28_2026To04_28_2026_6TypedMemberffdOfferingAxis"
      id="ixv-1382">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp
      contextRef="P04_28_2026To04_28_2026_6TypedMemberffdOfferingAxis"
      id="ixv-1383">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl
      contextRef="P04_28_2026To04_28_2026_6TypedMemberffdOfferingAxis"
      id="ixv-1384">Purchase Contracts</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg
      contextRef="P04_28_2026To04_28_2026_6TypedMemberffdOfferingAxis"
      id="ixv-1385">true</ffd:Rule457rFlg>
    <ffd:PrevslyPdFlg
      contextRef="P04_28_2026To04_28_2026_7TypedMemberffdOfferingAxis"
      id="ixv-1386">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp
      contextRef="P04_28_2026To04_28_2026_7TypedMemberffdOfferingAxis"
      id="ixv-1387">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl
      contextRef="P04_28_2026To04_28_2026_7TypedMemberffdOfferingAxis"
      id="ixv-1388">Warrants</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg
      contextRef="P04_28_2026To04_28_2026_7TypedMemberffdOfferingAxis"
      id="ixv-1389">true</ffd:Rule457rFlg>
    <ffd:PrevslyPdFlg
      contextRef="P04_28_2026To04_28_2026_8TypedMemberffdOfferingAxis"
      id="ixv-1390">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp
      contextRef="P04_28_2026To04_28_2026_8TypedMemberffdOfferingAxis"
      id="ixv-1391">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl
      contextRef="P04_28_2026To04_28_2026_8TypedMemberffdOfferingAxis"
      id="ixv-1392">Units</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg
      contextRef="P04_28_2026To04_28_2026_8TypedMemberffdOfferingAxis"
      id="ixv-1393">true</ffd:Rule457rFlg>
    <ffd:PrevslyPdFlg
      contextRef="P04_28_2026To04_28_2026_9TypedMemberffdOfferingAxis"
      id="ixv-1394">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp
      contextRef="P04_28_2026To04_28_2026_9TypedMemberffdOfferingAxis"
      id="ixv-1395">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl
      contextRef="P04_28_2026To04_28_2026_9TypedMemberffdOfferingAxis"
      id="ixv-1396">Common Stock, par value $0.0001 per share</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg
      contextRef="P04_28_2026To04_28_2026_9TypedMemberffdOfferingAxis"
      id="ixv-1397">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="P04_28_2026To04_28_2026_9TypedMemberffdOfferingAxis"
      decimals="0"
      id="ixv-1398"
      unitRef="Unit_USD">200000000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="P04_28_2026To04_28_2026_9TypedMemberffdOfferingAxis"
      decimals="INF"
      id="ixv-1399"
      unitRef="Unit_pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="P04_28_2026To04_28_2026_9TypedMemberffdOfferingAxis"
      decimals="0"
      id="ixv-1400"
      unitRef="Unit_USD">27620</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="P04_28_2026To04_28_2026"
      decimals="0"
      id="ixv-1401"
      unitRef="Unit_USD">200000000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="P04_28_2026To04_28_2026"
      decimals="0"
      id="ixv-1402"
      unitRef="Unit_USD">27620</ffd:TtlFeeAmt>
    <ffd:TtlOffsetAmt
      contextRef="P04_28_2026To04_28_2026"
      decimals="0"
      id="ixv-1403"
      unitRef="Unit_USD">27620</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="P04_28_2026To04_28_2026"
      decimals="0"
      id="ixv-1404"
      unitRef="Unit_USD">0</ffd:NetFeeAmt>
    <ffd:OfferingNote
      contextRef="P04_28_2026To04_28_2026_1TypedMemberffdOfferingAxis"
      id="ixv-761">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The amount to be registered consists of an indeterminate amount of common stock, preferred stock, debt securities, depositary shares, subscription rights, purchase contracts, warrants and/or units that may be offered and sold from time to time in one or more offerings, along with an indeterminate number of securities that may be issued upon exercise, settlement, exchange or conversion of securities offered or sold hereunder. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or pursuant to anti-dilution provisions of any of the securities. Separate consideration may or may not be received for securities that are issuable upon conversion, exercise or exchange of other securities. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The registrant hereby defers payment of the registration fee required by Section&#160;6(b) of the Securities Act pursuant to Rules 456(b) and 457(r) under the Securities Act, other than with respect to any registration fee associated with the primary offering of common stock described in the table in connection with the filing of this Registration Statement. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;       </ffd:OfferingNote>
    <ffd:OfferingNote
      contextRef="P04_28_2026To04_28_2026_2TypedMemberffdOfferingAxis"
      id="ixv-762">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The amount to be registered consists of an indeterminate amount of common stock, preferred stock, debt securities, depositary shares, subscription rights, purchase contracts, warrants and/or units that may be offered and sold from time to time in one or more offerings, along with an indeterminate number of securities that may be issued upon exercise, settlement, exchange or conversion of securities offered or sold hereunder. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or pursuant to anti-dilution provisions of any of the securities. Separate consideration may or may not be received for securities that are issuable upon conversion, exercise or exchange of other securities. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The registrant hereby defers payment of the registration fee required by Section&#160;6(b) of the Securities Act pursuant to Rules 456(b) and 457(r) under the Securities Act, other than with respect to any registration fee associated with the primary offering of common stock described in the table in connection with the filing of this Registration Statement. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;      </ffd:OfferingNote>
    <ffd:OfferingNote
      contextRef="P04_28_2026To04_28_2026_3TypedMemberffdOfferingAxis"
      id="ixv-763">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The amount to be registered consists of an indeterminate amount of common stock, preferred stock, debt securities, depositary shares, subscription rights, purchase contracts, warrants and/or units that may be offered and sold from time to time in one or more offerings, along with an indeterminate number of securities that may be issued upon exercise, settlement, exchange or conversion of securities offered or sold hereunder. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or pursuant to anti-dilution provisions of any of the securities. Separate consideration may or may not be received for securities that are issuable upon conversion, exercise or exchange of other securities. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The registrant hereby defers payment of the registration fee required by Section&#160;6(b) of the Securities Act pursuant to Rules 456(b) and 457(r) under the Securities Act, other than with respect to any registration fee associated with the primary offering of common stock described in the table in connection with the filing of this Registration Statement. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;     </ffd:OfferingNote>
    <ffd:OfferingNote
      contextRef="P04_28_2026To04_28_2026_7TypedMemberffdOfferingAxis"
      id="ixv-764">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The amount to be registered consists of an indeterminate amount of common stock, preferred stock, debt securities, depositary shares, subscription rights, purchase contracts, warrants and/or units that may be offered and sold from time to time in one or more offerings, along with an indeterminate number of securities that may be issued upon exercise, settlement, exchange or conversion of securities offered or sold hereunder. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or pursuant to anti-dilution provisions of any of the securities. Separate consideration may or may not be received for securities that are issuable upon conversion, exercise or exchange of other securities. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The registrant hereby defers payment of the registration fee required by Section&#160;6(b) of the Securities Act pursuant to Rules 456(b) and 457(r) under the Securities Act, other than with respect to any registration fee associated with the primary offering of common stock described in the table in connection with the filing of this Registration Statement. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;    </ffd:OfferingNote>
    <ffd:OfferingNote
      contextRef="P04_28_2026To04_28_2026_4TypedMemberffdOfferingAxis"
      id="ixv-765">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The amount to be registered consists of an indeterminate amount of common stock, preferred stock, debt securities, depositary shares, subscription rights, purchase contracts, warrants and/or units that may be offered and sold from time to time in one or more offerings, along with an indeterminate number of securities that may be issued upon exercise, settlement, exchange or conversion of securities offered or sold hereunder. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or pursuant to anti-dilution provisions of any of the securities. Separate consideration may or may not be received for securities that are issuable upon conversion, exercise or exchange of other securities. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The registrant hereby defers payment of the registration fee required by Section&#160;6(b) of the Securities Act pursuant to Rules 456(b) and 457(r) under the Securities Act, other than with respect to any registration fee associated with the primary offering of common stock described in the table in connection with the filing of this Registration Statement. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;   
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(3)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;Each depositary share will be issued under a deposit agreement, will represent an interest in fractional shares of preferred stock and will be evidenced by a depositary receipt. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ffd:OfferingNote>
    <ffd:OfferingNote
      contextRef="P04_28_2026To04_28_2026_5TypedMemberffdOfferingAxis"
      id="ixv-766">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The amount to be registered consists of an indeterminate amount of common stock, preferred stock, debt securities, depositary shares, subscription rights, purchase contracts, warrants and/or units that may be offered and sold from time to time in one or more offerings, along with an indeterminate number of securities that may be issued upon exercise, settlement, exchange or conversion of securities offered or sold hereunder. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or pursuant to anti-dilution provisions of any of the securities. Separate consideration may or may not be received for securities that are issuable upon conversion, exercise or exchange of other securities. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The registrant hereby defers payment of the registration fee required by Section&#160;6(b) of the Securities Act pursuant to Rules 456(b) and 457(r) under the Securities Act, other than with respect to any registration fee associated with the primary offering of common stock described in the table in connection with the filing of this Registration Statement. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;  
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(4)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The subscription rights may be issued independently or together with any other security and may or may not be transferable. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ffd:OfferingNote>
    <ffd:OfferingNote
      contextRef="P04_28_2026To04_28_2026_6TypedMemberffdOfferingAxis"
      id="ixv-767">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The amount to be registered consists of an indeterminate amount of common stock, preferred stock, debt securities, depositary shares, subscription rights, purchase contracts, warrants and/or units that may be offered and sold from time to time in one or more offerings, along with an indeterminate number of securities that may be issued upon exercise, settlement, exchange or conversion of securities offered or sold hereunder. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or pursuant to anti-dilution provisions of any of the securities. Separate consideration may or may not be received for securities that are issuable upon conversion, exercise or exchange of other securities. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The registrant hereby defers payment of the registration fee required by Section&#160;6(b) of the Securities Act pursuant to Rules 456(b) and 457(r) under the Securities Act, other than with respect to any registration fee associated with the primary offering of common stock described in the table in connection with the filing of this Registration Statement. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; 
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(5)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The purchase contracts may be issued separately or as a part of units consisting of a purchase contract and either shares of common stock, shares of preferred stock, the registrant&#x2019;s debt securities or debt obligations of third parties, including U.S. Treasury securities, any other security described in the applicable prospectus supplement, or any combination of the foregoing, securing the holder&#x2019;s obligations to purchase the securities under the share purchase contracts. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ffd:OfferingNote>
    <ffd:OfferingNote
      contextRef="P04_28_2026To04_28_2026_8TypedMemberffdOfferingAxis"
      id="ixv-768">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The amount to be registered consists of an indeterminate amount of common stock, preferred stock, debt securities, depositary shares, subscription rights, purchase contracts, warrants and/or units that may be offered and sold from time to time in one or more offerings, along with an indeterminate number of securities that may be issued upon exercise, settlement, exchange or conversion of securities offered or sold hereunder. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or pursuant to anti-dilution provisions of any of the securities. Separate consideration may or may not be received for securities that are issuable upon conversion, exercise or exchange of other securities. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The registrant hereby defers payment of the registration fee required by Section&#160;6(b) of the Securities Act pursuant to Rules 456(b) and 457(r) under the Securities Act, other than with respect to any registration fee associated with the primary offering of common stock described in the table in connection with the filing of this Registration Statement. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(6)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;Each unit will be issued under a unit agreement and will represent an interest in two or more securities registered pursuant to this registration statement, which may or may not be separable from one another. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ffd:OfferingNote>
    <ffd:Rule457pOffsetFlg
      contextRef="P04_28_2026To04_28_2026_1TypedMemberffdOffsetAxis"
      id="ixv-1405">true</ffd:Rule457pOffsetFlg>
    <ffd:Rule457pOffsetFlg
      contextRef="P04_28_2026To04_28_2026_2TypedMemberffdOffsetAxis"
      id="ixv-1406">true</ffd:Rule457pOffsetFlg>
    <ffd:OffsetPrrFilerNm
      contextRef="P04_28_2026To04_28_2026_1TypedMemberffdOffsetAxis"
      id="ixv-1407">Cullinan Therapeutics, Inc.</ffd:OffsetPrrFilerNm>
    <ffd:OffsetPrrFormTp
      contextRef="P04_28_2026To04_28_2026_1TypedMemberffdOffsetAxis"
      id="ixv-1408">S-3</ffd:OffsetPrrFormTp>
    <ffd:OffsetPrrFileNb
      contextRef="P04_28_2026To04_28_2026_1TypedMemberffdOffsetAxis"
      id="ixv-1409">333-270384</ffd:OffsetPrrFileNb>
    <ffd:OffsetClmInitlFilgDt
      contextRef="P04_28_2026To04_28_2026_1TypedMemberffdOffsetAxis"
      id="ixv-1410">2023-03-09</ffd:OffsetClmInitlFilgDt>
    <ffd:OffsetClmdAmt
      contextRef="P04_28_2026To04_28_2026_1TypedMemberffdOffsetAxis"
      decimals="0"
      id="ixv-1411"
      unitRef="Unit_USD">27620</ffd:OffsetClmdAmt>
    <ffd:OffsetPrrSctyTitl
      contextRef="P04_28_2026To04_28_2026_1TypedMemberffdOffsetAxis"
      id="ixv-1412">Unallocated (Universal)Shelf</ffd:OffsetPrrSctyTitl>
    <ffd:OffsetPrrNbOfUnsoldScties
      contextRef="P04_28_2026To04_28_2026_1TypedMemberffdOffsetAxis"
      decimals="0"
      id="ixv-1413"
      unitRef="Unit_shares">35934291</ffd:OffsetPrrNbOfUnsoldScties>
    <ffd:OffsetPrrUnsoldOfferingAmt
      contextRef="P04_28_2026To04_28_2026_1TypedMemberffdOffsetAxis"
      decimals="0"
      id="ixv-1414"
      unitRef="Unit_USD">310628094</ffd:OffsetPrrUnsoldOfferingAmt>
    <ffd:OffsetClmdInd
      contextRef="P04_28_2026To04_28_2026_2TypedMemberffdOffsetAxis"
      id="ixv-1415">false</ffd:OffsetClmdInd>
    <ffd:OffsetPrrFilerNm
      contextRef="P04_28_2026To04_28_2026_2TypedMemberffdOffsetAxis"
      id="ixv-1416">Cullinan Therapeutics, Inc.</ffd:OffsetPrrFilerNm>
    <ffd:OffsetPrrFormTp
      contextRef="P04_28_2026To04_28_2026_2TypedMemberffdOffsetAxis"
      id="ixv-1417">S-3</ffd:OffsetPrrFormTp>
    <ffd:OffsetPrrFileNb
      contextRef="P04_28_2026To04_28_2026_2TypedMemberffdOffsetAxis"
      id="ixv-1418">333-270384</ffd:OffsetPrrFileNb>
    <ffd:OffsetSrcFilgDt
      contextRef="P04_28_2026To04_28_2026_2TypedMemberffdOffsetAxis"
      id="ixv-1419">2023-03-09</ffd:OffsetSrcFilgDt>
    <ffd:OffsetPrrFeeAmt
      contextRef="P04_28_2026To04_28_2026_2TypedMemberffdOffsetAxis"
      decimals="0"
      id="ixv-1420"
      unitRef="Unit_USD">38570</ffd:OffsetPrrFeeAmt>
    <ffd:TermntnCmpltnWdrwl
      contextRef="P04_28_2026To04_28_2026_1TypedMemberffdOffsetAxis"
      id="ixv-1092">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The amount to be registered consists of an indeterminate amount of common stock, preferred stock, debt securities, depositary shares, subscription rights, purchase contracts, warrants and/or units that may be offered and sold from time to time in one or more offerings, along with an indeterminate number of securities that may be issued upon exercise, settlement, exchange or conversion of securities offered or sold hereunder. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or pursuant to anti-dilution provisions of any of the securities. Separate consideration may or may not be received for securities that are issuable upon conversion, exercise or exchange of other securities. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The registrant hereby defers payment of the registration fee required by Section&#160;6(b) of the Securities Act pursuant to Rules 456(b) and 457(r) under the Securities Act, other than with respect to any registration fee associated with the primary offering of common stock described in Table 1 in connection with the filing of this Registration Statement. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(3)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;Pursuant to Rule 457(p) under the Securities Act, the securities registered pursuant to this registration statement include $310,628,094 of unsold shares (the &#x201c;Unsold Securities&#x201d;) of common stock, preferred stock, debt securities, depositary shares, subscription rights, purchase contracts, warrants and/or units previously registered pursuant to a prospectus filed with the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on March&#160;9, 2023, as amended (the &#x201c;Prior Prospectus&#x201d;), to the Registration Statement on Form &lt;div style="white-space:nowrap;display:inline;"&gt;S-3&lt;/div&gt; (File &lt;div style="white-space:nowrap;display:inline;"&gt;No.&#160;333-2703844),&lt;/div&gt; which was filed with the SEC on March&#160;9, 2023, as amended (the &#x201c;Prior Registration Statement&#x201d;), relating to the offer and sale of common stock, preferred stock, debt securities, depositary shares, subscription rights, purchase contracts, warrants and/or units having an aggregate offering price of up to $350,000,000, including $125,000,000 in connection with the Registrant&#x2019;s &lt;div style="white-space:nowrap;display:inline;"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;at-the-market&lt;/div&gt;&lt;/div&gt; offering program. In connection with the filing of the Prior Prospectus, the registrant made a contemporaneous fee payment in the amount of $38,570. As of the date of this registration statement, shares of Common Stock having an aggregate offering price of up to $310,628,094 were not sold under the Prior Prospectus, and the registration fee that has already been paid and remains unused with respect to the Unsold Securities will be applied to shares of common stock that are being registered pursuant to this registration statement. Pursuant to Rule 457(p), the offering of the Unsold Securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this registration statement. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ffd:TermntnCmpltnWdrwl>
    <ffd:TermntnCmpltnWdrwl
      contextRef="P04_28_2026To04_28_2026_2TypedMemberffdOffsetAxis"
      id="ixv-1093">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The amount to be registered consists of an indeterminate amount of common stock, preferred stock, debt securities, depositary shares, subscription rights, purchase contracts, warrants and/or units that may be offered and sold from time to time in one or more offerings, along with an indeterminate number of securities that may be issued upon exercise, settlement, exchange or conversion of securities offered or sold hereunder. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or pursuant to anti-dilution provisions of any of the securities. Separate consideration may or may not be received for securities that are issuable upon conversion, exercise or exchange of other securities. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;The registrant hereby defers payment of the registration fee required by Section&#160;6(b) of the Securities Act pursuant to Rules 456(b) and 457(r) under the Securities Act, other than with respect to any registration fee associated with the primary offering of common stock described in Table 1 in connection with the filing of this Registration Statement. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left"&gt;(3)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"&gt;Pursuant to Rule 457(p) under the Securities Act, the securities registered pursuant to this registration statement include $310,628,094 of unsold shares (the &#x201c;Unsold Securities&#x201d;) of common stock, preferred stock, debt securities, depositary shares, subscription rights, purchase contracts, warrants and/or units previously registered pursuant to a prospectus filed with the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on March&#160;9, 2023, as amended (the &#x201c;Prior Prospectus&#x201d;), to the Registration Statement on Form &lt;div style="white-space:nowrap;display:inline;"&gt;S-3&lt;/div&gt; (File &lt;div style="white-space:nowrap;display:inline;"&gt;No.&#160;333-2703844),&lt;/div&gt; which was filed with the SEC on March&#160;9, 2023, as amended (the &#x201c;Prior Registration Statement&#x201d;), relating to the offer and sale of common stock, preferred stock, debt securities, depositary shares, subscription rights, purchase contracts, warrants and/or units having an aggregate offering price of up to $350,000,000, including $125,000,000 in connection with the Registrant&#x2019;s &lt;div style="white-space:nowrap;display:inline;"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;at-the-market&lt;/div&gt;&lt;/div&gt; offering program. In connection with the filing of the Prior Prospectus, the registrant made a contemporaneous fee payment in the amount of $38,570. As of the date of this registration statement, shares of Common Stock having an aggregate offering price of up to $310,628,094 were not sold under the Prior Prospectus, and the registration fee that has already been paid and remains unused with respect to the Unsold Securities will be applied to shares of common stock that are being registered pursuant to this registration statement. Pursuant to Rule 457(p), the offering of the Unsold Securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this registration statement. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ffd:TermntnCmpltnWdrwl>
</xbrl>
